Virinchi Limited , a technology solutions provider, conducted an Extra-Ordinary General Meeting (EGM) on November 15, 2025, to address key corporate actions. The meeting, held via video conferencing, saw the participation of 59 public members who gathered to vote on significant proposals.

Key Agenda Items

1. Issuance of Convertible Equity Warrants: The primary focus of the EGM was to seek approval for issuing convertible equity warrants to identified promoter and non-promoter entities on a preferential basis. This move could potentially impact the company's capital structure and ownership patterns.

2. Revision of Promoter Remuneration: The meeting also addressed the revision in remuneration for Mr. Viswanath Kompella, the promoter Chairman Emeritus of Virinchi Limited, in his capacity as an advisor to the company.

Meeting Details

• Ms. Priya Rajender Goda: Independent Director
• Mr. Sri Kalyan Kompella: Non-Executive Director
• Mr. Shyam Sunder Tipparaju: Independent Director
• Mr. Satyanarayana Vedula: Wholetime Director
• Mr. M V Srinivasa Rao: Wholetime Director & CFO |

Voting Process

The company implemented remote e-voting facilities to ensure shareholder participation. The e-voting window remained open for 15 minutes after the conclusion of the meeting, which ended at 03:48 p.m.

Result Announcement

Virinchi Limited stated that the voting results would be announced by November 18, 2025. These results will provide clarity on the approval status of the proposed equity warrants issuance and the revision in Mr. Kompella's remuneration.

Compliance and Transparency

The EGM was conducted in compliance with the circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India (SEBI). This adherence to regulatory guidelines underscores Virinchi Limited's commitment to corporate governance and transparency in its operations.

Investors and stakeholders are advised to keep an eye on the company's official communications for the detailed voting results and the implications of these corporate actions on Virinchi Limited's future strategies and financial position.

Virinchi Limited has announced a crucial board meeting scheduled for August 22, 2025, to deliberate on strategic business restructuring plans that could significantly impact the company's future direction.

Key Agenda Items

The board meeting, set to take place at the company's registered office, will focus on two major strategic initiatives:

1. SaaS Business Restructuring: The company is considering restructuring its Software as a Service (SaaS) business into a wholly-owned subsidiary through a slump sale. This move is aimed at creating a focused SaaS entity and potentially unlocking long-term shareholder value.

2. Partial Divestment and Fund Allocation: Virinchi is exploring options to divest a portion of its SaaS business. The company is considering various avenues for this divestment, including private investment, strategic partnerships, or an Initial Public Offering (IPO).

Strategic Objectives

The proposed restructuring and divestment plans are designed to achieve multiple strategic objectives:

1. Debt Reduction: Proceeds from the potential divestment of the SaaS business are intended to be used for reducing debt at the consolidated level, which could improve the company's financial health.

2. Healthcare Expansion: Part of the funds raised through the divestment is planned to be invested in the oncology healthcare vertical. This investment aims to support the expansion of the Virinchi hospital chain, potentially strengthening the company's presence in the healthcare sector.

3. Focused Growth: By creating a separate entity for the SaaS business, Virinchi Limited appears to be positioning itself for more focused growth and potentially enhanced operational efficiency in both its technology and healthcare verticals.

Investor Implications

These strategic moves, if approved and implemented, could have significant implications for Virinchi's shareholders:

• The creation of a focused SaaS subsidiary might lead to better valuation and visibility for this business segment.
• Debt reduction could improve the company's financial ratios and potentially its market perception.
• Expansion in the healthcare sector might diversify revenue streams and create new growth opportunities.

Investors and market watchers will be keenly awaiting the outcomes of this board meeting, as the decisions made could shape Virinchi Limited's business structure and growth trajectory in the coming years.

The company has duly informed the stock exchanges about this upcoming board meeting, in compliance with regulatory requirements.

Note: This article is based on the company's official communication to stock exchanges. Investors are advised to consult financial experts before making any investment decisions.